CLINICAL_TRIALS
trial_result
· 2025-08-01
Clinical Trial Update: Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer [Phase 3]
Summary
A Phase 3 trial evaluating Taxoprexin with carboplatin for advanced non-small cell lung cancer has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: American Regent, Inc. | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-08-01